These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation. Vierimaa O; Ebeling TM; Kytölä S; Bloigu R; Eloranta E; Salmi J; Korpi-Hyövälti E; Niskanen L; Orvola A; Elovaara E; Gynther A; Sane T; Välimäki M; Ignatius J; Leisti J; Salmela PI Eur J Endocrinol; 2007 Sep; 157(3):285-94. PubMed ID: 17766710 [TBL] [Abstract][Full Text] [Related]
23. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients. Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A; Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours. Langer P; Wild A; Hall A; Celik I; Rothmund M; Bartsch DK Br J Surg; 2003 Dec; 90(12):1599-603. PubMed ID: 14648742 [TBL] [Abstract][Full Text] [Related]
25. [Results of multiple endocrine neoplasia type 1 in Japan from a multicenter database]. Suzuki S Nihon Geka Gakkai Zasshi; 2012 Jul; 113(4):356-61. PubMed ID: 22928440 [TBL] [Abstract][Full Text] [Related]
26. Multiple endocrine neoplasia type 1 in Poland: a two-centre experience. Soczomski P; Jurecka-Lubieniecka B; Rogozik N; Tukiendorf A; Jarząb B; Bednarczuk T Endokrynol Pol; 2019; 70(5):385-391. PubMed ID: 31274185 [TBL] [Abstract][Full Text] [Related]
27. [Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT]. Frank-Raue K; Leidig-Bruckner G; Lorenz A; Rondot S; Haag C; Schulze E; Büchler M; Raue F Dtsch Med Wochenschr; 2011 Sep; 136(38):1889-94. PubMed ID: 21915802 [TBL] [Abstract][Full Text] [Related]
30. Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1. Owens M; Ellard S; Vaidya B Clin Endocrinol (Oxf); 2008 Mar; 68(3):350-4. PubMed ID: 17854391 [TBL] [Abstract][Full Text] [Related]
31. Novel MEN1 gene mutations in familial multiple endocrine neoplasia type 1. Sakurai A; Shirahama S; Fujimori M; Katai M; Itakura Y; Kobayashi S; Amano J; Fukushima Y; Hashizume K J Hum Genet; 1998; 43(3):199-201. PubMed ID: 9747036 [TBL] [Abstract][Full Text] [Related]
32. Novel 14 base-pair deletion of the MEN1 gene in a patient with recurrent primary hyperparathyroidism. Katai M; Sakurai A; Uchino S; Minemura K; Hashizume K; Fukushima Y Jpn J Clin Oncol; 2006 Jun; 36(6):395-7. PubMed ID: 16714299 [TBL] [Abstract][Full Text] [Related]
33. MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors. Vannucci L; Marini F; Giusti F; Ciuffi S; Tonelli F; Brandi ML Endocrine; 2018 Feb; 59(2):438-448. PubMed ID: 28530019 [TBL] [Abstract][Full Text] [Related]
34. Multimodal treatment of sporadic and inherited neuroendocrine tumors of the thymus. Habbe N; Waldmann J; Bartsch DK; Fendrich V; Rothmund M; Langer P Surgery; 2008 Nov; 144(5):780-5. PubMed ID: 19081021 [TBL] [Abstract][Full Text] [Related]
35. Clinical and prognostic implications of the genetic diagnosis of hereditary NET syndromes in asymptomatic patients. Ramundo V; Milone F; Severino R; Savastano S; Di Somma C; Vuolo L; De Luca L; Lombardi G; Colao A; Faggiano A Horm Metab Res; 2011 Oct; 43(11):794-800. PubMed ID: 22009375 [TBL] [Abstract][Full Text] [Related]
36. Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study Group. van Leeuwaarde RS; van Nesselrooij BP; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Vriens MR; de Laat JM; Pieterman CR; Valk GD J Clin Endocrinol Metab; 2016 Mar; 101(3):1159-65. PubMed ID: 26751192 [TBL] [Abstract][Full Text] [Related]
37. [Germline mutations in the MEN1 gene: basis for predictive genetic screening and clinical management of multiple endocrine neoplasia type 1 (MEN1) families]. Bartsch D; Kopp I; Bergenfelz A; Rieder H; Deiss Y; Münch K; Rothmund M; Simon B Dtsch Med Wochenschr; 1998 Dec; 123(51-52):1535-40. PubMed ID: 9893679 [TBL] [Abstract][Full Text] [Related]
38. Identification of multiple endocrine neoplasia type 1 in patients with apparent sporadic primary hyperparathyroidism. Yip L; Ogilvie JB; Challinor SM; Salata RA; Thull DL; Yim JH; Carty SE Surgery; 2008 Dec; 144(6):1002-6; discussion 1006-7. PubMed ID: 19041010 [TBL] [Abstract][Full Text] [Related]
39. ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1). Damjanovic SS; Antic JA; Elezovic-Kovacevic VI; Dundjerovic DM; Milicevic IT; Beleslin-Cokic BB; Ilic BB; Rodic GS; Berthon A; Maria AG; Faucz FR; Stratakis CA J Clin Endocrinol Metab; 2020 Dec; 105(12):e4531-42. PubMed ID: 32901291 [TBL] [Abstract][Full Text] [Related]
40. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India. Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]